- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03780946
Magnetic Compressive Technique for Pancreatic Intestinal Anastomosis (MCTPIA)
November 10, 2019 updated by: First Affiliated Hospital Xi'an Jiaotong University
In recent five years, the investigators have successfully developed different types of magnets and utilized in biliojejunostomy, concomitant biliojejunostomy and pancreaticojejunostomy during Whipple.
This study is designed as a prospective study by utilization of the bar-like magnets for pancreaticojejunostomy.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Magnetic anastomosis has been attempted in continuous connection between bowel and bowel, vessels and vessels, biliary and gastrointestinal tracts, as well as in recanalization of the biliary stricture, and bilioenteric anastomotic stricture.
During the past 15 years, the investigators have designed different types of magnets, and attempted these magnets in vascular, intestine, and biliary anastomosis in preclinical studies.
In recent five years, we have successfully developed different types of magnets and utilized in biliojejunostomy, concomitant biliojejunostomy and pancreaticojejunostomy during Whipple.
This study is designed as a prospective study by utilization of the bar-like magnets for pancreaticojejunostomy.
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lv Yi, MD, PhD
- Phone Number: 86-29-85323900
- Email: luyi169@126.com
Study Contact Backup
- Name: Xu-Feng Zhang, MD, PhD
- Phone Number: 86-29-85323626
- Email: xfzhang125@126.com
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710061
- Recruiting
- The First Affiliated Hospital of Xi'an Jiaotong University
-
Contact:
- Xu-Feng Zhang, MD, PhD
- Phone Number: 86 29 85323900
- Email: xfzhang125@126.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
- Patients with pancreatic neoplasm who needs pancreatic head resection, or central pancreatectomy or partial pancreatectomy, and then pancreaticojejunostomy.
- Patients with dilated pancreatic duct secondary to chronic pancreatitis who needs Frey's procedure.
- Patients with pancreatic injury who needs pancreatic head resection, or central pancreatectomy or partial pancreatectomy, and then pancreaticojejunostomy.
- Patients who are willing to join this clinical trial and informed consent form voluntarily.
Description
Inclusion Criteria:
- Patients with pancreatic neoplasm who needs pancreatic head resection, or central pancreatectomy or partial pancreatectomy, and then pancreaticojejunostomy
- Patients with dilated pancreatic duct secondary to chronic pancreatitis who needs Frey's procedure
- Patients with pancreatic injury who needs pancreatic head resection, or central pancreatectomy or partial pancreatectomy, and then pancreaticojejunostomy
Exclusion Criteria:
- Woman during pregnancy or lactation or anyone with mental disorder
- The wall of pancreatic incision is too thick so that the attractive force of magnetic device cannot meet the requirements of compression
- Any foreign body has been implanted in body, such as heart pacemaker.
- Surgical contraindication, including Child-Pugh C with hepatic encephalopathy, and anyone with heart, lung, kidney dysfunction or other organ dysfunction, and cannot tolerate surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Magnetic group
Magnetic anastomosis for pancreaticojejunostomy
|
Magnetic anastomosis for pancreaticojejunostomy
|
Control group
Traditional hand-sewn for pancreaticojejunostomy
|
Traditional manual anastomosis for pancreaticojejunostomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pancreatic fistula
Time Frame: From date of surgery to one month postoperatively
|
Leakage of pancreatic fistula, which is defined according to Clinically relevant Pancreatic fistula (PF) was defined by the International Study Group of Pancreatic Surgery in 2016: a drain output of any measurable volume of fluid with an amylase level >3 times the upper limit of institutional normal serum amylase activity.
|
From date of surgery to one month postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anastomotic stricture
Time Frame: one year from the date of surgery
|
Anastomotic stricture, which will be verified by imaging studies or endoscopic investigations
|
one year from the date of surgery
|
Discharge of the magnets
Time Frame: 3 months from the date of surgery
|
X-ray plain film is performed regularly to check the movement and discharge of the magnets
|
3 months from the date of surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yi Lv, MD, PhD, First Affiliated Hospital Xi'an Jiaotong University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2019
Primary Completion (ANTICIPATED)
January 31, 2021
Study Completion (ANTICIPATED)
January 31, 2022
Study Registration Dates
First Submitted
December 12, 2018
First Submitted That Met QC Criteria
December 17, 2018
First Posted (ACTUAL)
December 19, 2018
Study Record Updates
Last Update Posted (ACTUAL)
November 13, 2019
Last Update Submitted That Met QC Criteria
November 10, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XJTU1AF-CRF-2015-001-3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Neoplasms
-
Memorial Sloan Kettering Cancer CenterRecruitingPancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Stage IV | Metastatic Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Pancreatic Carcinoma | Metastatic Pancreatic Cancer | Pancreatic Cancer Non-resectable | Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingLocally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Pancreatic NeoplasmChina
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer
-
National Cancer Institute (NCI)CompletedStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of OxfordNational Institute for Health Research, United Kingdom; ImunonWithdrawnPancreatic Cancer Metastatic | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IV | Pancreatic Cancer Non-resectableUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAdvanced Pancreatic Carcinoma | Metastatic Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Unresectable Pancreatic Carcinoma | Pancreatic Neoplasm | Locally Advanced Pancreatic CarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Celgene CorporationCompletedPancreatic Adenocarcinoma | Resectable Pancreatic CarcinomaUnited States
Clinical Trials on Magnetic anastomosis for pancreaticojejunostomy
-
Karolinska InstitutetUniversity Hospital, LinkoepingCompletedPancreatic FistulaSweden
-
First Affiliated Hospital Xi'an Jiaotong UniversityHealth Science Center of Xi'an Jiaotong University; Northwest Institute for...UnknownPancreatic Cancer | Cholangiocarcinoma | Bile Duct Injury | Choledochal Cyst | Biliary CalculiChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Shaanxi Provincial People... and other collaboratorsUnknownHilar Cholangiocarcinoma | Bile Duct Injury | Choledochal Cyst | Biliary CalculiChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknownPancreatic Neoplasms | Cholangiocarcinoma | Chronic Pancreatitis | Duodenal Neoplasms | PancreatolithiasisChina
-
Michael HarrisonUniversity of California, San FranciscoCompletedIntestinal Anastomosis ComplicationUnited States
-
GI Windows, Inc.Active, not recruitingObesity | Type 2 Diabetes MellitusCanada
-
GI Windows, Inc.Active, not recruiting
-
Centre Hospitalier Universitaire de BesanconNot yet recruiting
-
Cook Group IncorporatedMED Institute, Incorporated; Cook EndoscopyTerminatedGastric Outlet ObstructionNetherlands, Belgium, Italy
-
GI Windows, Inc.Recruiting